Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Kalogeropoulos, V. Georgiopoulou, S. Kritchevsky, B. Psaty, N. Smith, A. Newman, N. Rodondi, S. Satterfield, D. Bauer, K. Bibbins-Domingo, Andrew Smith, P. Wilson, R. Vasan, T. Harris, J. Butler (2009)
Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study.Archives of internal medicine, 169 7
S. Rahimtoola (2004)
Digitalis Therapy for Patients in Clinical Heart FailureCirculation, 109
D. Vulic, Brian Lee, J. Dede, Victor Lopez, N. Wong (2010)
Extent of Control of Cardiovascular Risk Factors and Adherence to Recommended Therapies in US Multiethnic Adults with Coronary Heart DiseaseAmerican Journal of Cardiovascular Drugs, 10
R. Kociol, E. Peterson, B. Hammill, K. Flynn, P. Heidenreich, I. Piña, B. Lytle, N. Albert, L. Curtis, G. Fonarow, Adrian Hernandez (2012)
National Survey of Hospital Strategies to Reduce Heart Failure Readmissions: Findings From the Get With the Guidelines-Heart Failure RegistryCirculation: Heart Failure, 5
P. Thompson, D. Buchner, I. Piña, G. Balady, Mark Williams, B. Marcus, K. Berra, S. Blair, F. Costa, B. Franklin, G. Fletcher, N. Gordon, R. Pate, B. Rodríguez, A. Yancey, N. Wenger (2003)
Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on PhCirculation, 107 24
S. Hart (2000)
Influence of beta-blockers on mortality in chronic heart failure.The Annals of pharmacotherapy, 34 12
K. Dickstein, A. Cohen-Solal, G. Filippatos, J. McMurray, P. Ponikowski, P. Poole‐Wilson, A. Strömberg, D. Veldhuisen, D. Atar, A. Hoes, A. Keren, A. Mebazaa, Markku Nieminen, S. Priori, K. Swedberg, A. Vahanian, J. Camm, R. Caterina, V. Dean, C. Funck-Brentano, I. Hellemans, S. Kristensen, K. Mcgregor, U. Sechtem, S. Silber, M. Tendera, Petr Widimsky, J. Zamorano, A. Auricchio, Jeroen Bax, M. Böhm, U. Corrà, P. Bella, P. Elliott, F. Follath, M. Gheorghiade, Y. Hasin, A. Hernborg, T. Jaarsma, M. Komajda, R. Kornowski, M. Piepoli, B. Prendergast, L. Tavazzi, J. Vachiéry, F. Verheugt, F. Zannad (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 ‡European Journal of Heart Failure, 10
(2005)
Z.: Micromixers – a review
C. Sueta, M. Massing, M. Chowdhury, D. Biggs, R. Simpson (2003)
Undertreatment of hyperlipidemia in patients with coronary artery disease and heart failure.Journal of cardiac failure, 9 1
B. Pitt, F. Zannad, W. Remme, R. Cody, A. Castaigne, Alfonso Perez, J. Palensky, J. Wittes (1999)
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.The New England journal of medicine, 341 10
R. Garg, S. Yusuf (1995)
Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 273
(2010)
Etiology, comorbidity and prognosis of hospitalized patients with congestive heart failure
G. Fabbri, M. Gorini, A. Maggioni, G. Cacciatore, A. Lenarda (2006)
[Italian Network on Congestive Heart Failure: ten-year experience].Giornale italiano di cardiologia, 7 10
C. Yancy, M. Jessup, B. Bozkurt, J. Butler, D. Casey, M. Drazner, G. Fonarow, S. Geraci, T. Horwich, J. Januzzi, Maryl Johnson, E. Kasper, W. Levy, F. Masoudi, P. Mcbride, J. McMurray, J. Mitchell, Pamela Peterson, B. Riegel, F. Sam, L. Stevenson, W. Tang, E. Tsai, B. Wilkoff (2013)
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Journal of the American College of Cardiology, 62 16
H. Taegtmeyer, C. Wilson (2002)
Obesity and the risk of heart failure.The New England journal of medicine, 347 23
Benno Tol, R. Huijsmans, Dineke Kroon, M. Schothorst, G. Kwakkel (2006)
Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: A meta‐analysisEuropean Journal of Heart Failure, 8
C. Anderson, B. Deepak, Y. Amoateng‐Adjepong, S. Zarich (2005)
Benefits of comprehensive inpatient education and discharge planning combined with outpatient support in elderly patients with congestive heart failure.Congestive heart failure, 11 6
K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. Smiseth, A. Gavazzi, A. Haverich, A. Hoes, T. Jaarsma, J. Korewicki, Samuel Lévy, C. Linde, J. López-Sendón, M. Nieminen, L. Pierard, W. Remme (2005)
Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.European heart journal, 26 11
D Vulic, BT Lee, J Dede, VA Lopez, ND Wong (2010)
Extent of control of cardiovascular risk factors and adherence to recommended therapies in US multiethnic adults with coronary heart disease: from a 2005–2006 National SurveyAm J Cardivasc Drugs, 10
R. Mehta, Cecelia Montoye, M. Gallogly, Patricia Baker, A. Blount, J. Faul, Canopy Roychoudhury, S. Borzak, Susan Fox, Mary Franklin, Marge Freundl, E. Kline-Rogers, Thomas Lalonde, M. Orza, R. Parrish, Martha Satwicz, M. Smith, P. Sobotka, Stuart Winston, A. Riba, K. Eagle (2002)
Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative.JAMA, 287 10
Jiang He, L. Ogden, L. Bazzano, S. Vupputuri, C. Loria, P. Whelton (2001)
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study.Archives of internal medicine, 161 7
S Kenchaiah, JC Evans, D Levy (2002)
Obesity and the risk of heart failure; the Framingham StudyN Engl J Med., 347
A. Shah, M. Pfeffer, L. Hartley, L. Moye, B. Gersh, John Rutherford, G. Lamas, J. Rouleau, E. Braunwald, S. Solomon (2010)
Risk of all-cause mortality, recurrent myocardial infarction, and heart failure hospitalization associated with smoking status following myocardial infarction with left ventricular dysfunction.The American journal of cardiology, 106 7
W. Colucci (2015)
Overview of the therapy of heart failure due to systolic dysfunction
M. Macdonald, D. Eurich, S. Majumdar, J. Lewsey, S. Bhagra, P. Jhund, M. Petrie, J. McMurray, J. Petrie, F. McAlister (2010)
Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case–Control Study From the U.K. General Practice Research DatabaseDiabetes Care, 33
R. Garg, S. Yusuf (1995)
Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials.JAMA, 273 18
M. Hall, Shaleah Levant, Carol DeFrances (2012)
Hospitalization for congestive heart failure: United States, 2000-2010.NCHS data brief, 108
R. Lopert, Samantha Shoemaker, A. Davidoff, T. Shaffer, A. Abdulhalim, Jennifer Lloyd, B. Stuart (2012)
Medication adherence and Medicare expenditure among beneficiaries with heart failure.The American journal of managed care, 18 9
J Lindenfeld, NM Albert, JP Boehmer (2010)
Heart Failure Society of America. Evaluation of patients for ventricular dysfunction and heart failure: HFSA 2010 comprehensive heart failure practice guidelineJ Card Fail, 16
J Wu, DD Sin (2011)
Improved patient outcome with smoking cessation: when is it too late?Int J Chron Obstruct Pulmon Dis, 6
S. Hart (2000)
Influence of β -Blockers on Mortality in Chronic Heart FailureAnnals of Pharmacotherapy, 34
Allison Pritchett, A. Deswal, D. Aguilar, J. Foreyt, W. Chan, D. Mann, C. Ballantyne, B. Bozkurt (2012)
Lifestyle Modification with Diet and Exercise in Obese Patients with Heart Failure - A Pilot Study.Journal of obesity & weight loss therapy, 2 2
K Dickstein, A Cohen-Solal, G Filippatos (2008)
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Eur Heart J, 29
A. Elixhauser, C. Steiner (2013)
Readmissions to U.S. Hospitals by Diagnosis, 2010
Ryenn West, L. Liang, G. Fonarow, R. Kociol, R. Mills, C. O’Connor, Adrian Hernandez (2011)
Characterization of heart failure patients with preserved ejection fraction: a comparison between ADHERE‐US registry and ADHERE‐International registryEuropean Journal of Heart Failure, 13
J. Udell, J. Ray (2006)
Primary and secondary prevention of heart failure with statinsExpert Review of Cardiovascular Therapy, 4
Jiang He, L. Ogden, L. Bazzano, S. Vupputuri, C. Loria, P. Whelton (2002)
Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.Archives of internal medicine, 162 14
P. Abete, G. Testa, D. Della-Morte, G. Gargiulo, G. Galizia, D. Santis, A. Magliocca, C. Basile, F. Cacciatore (2013)
Treatment for chronic heart failure in the elderly: current practice and problemsHeart Failure Reviews, 18
(2013)
Effects of exercise on ejection fraction, arrhythmias, dyspnea, and functional capacity in congestive heart failure patients
J. Lindenfeld, N. Albert, J. Boehmer, S. Collins, J. Ezekowitz, M. Givertz, S. Katz, M. Klapholz, D. Moser, J. Rogers, R. Starling, W. Stevenson, W. Tang, J. Teerlink, M. Walsh (2010)
HFSA 2010 Comprehensive Heart Failure Practice Guideline.Journal of cardiac failure, 16 6
M. Chow (1993)
Assessing the Treatment of Congestive Heart Failure: Diuretics, Vasodilators, and Angiotensin‐Converting Enzyme InhibitorsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 13
Am J Cardiovasc Drugs (2014) 14:41–49 DOI 10.1007/s40256-013-0046-z OR IGINAL RESEARCH ARTIC L E Examining Risk Factor Goal Attainment and Adherence to Treatment Among US Heart Failure Patients: The National Health and Nutrition Examination Survey 2007–2010 • • Tsering Gyalpo Lama Tamang Lijiang Tang • • Joanna Chuang Rohini J. Patel Nathan D. Wong Published online: 9 October 2013 Springer International Publishing Switzerland 2013 Abstract taking only one of the recommended four classes of drugs Purpose Data are limited regarding the adequacy of risk [b-blockers, angiotensin converting enzyme inhibitors/ factor control and adherence to recommended therapies angiotensin receptor blockers (ACEIs/ARBs), diuretics, among adults with heart failure (HF). We evaluated the and digoxin]; only 50.1 % were additionally on a lipid- adequacy of risk factor control and adherence to recom- lowering agent. mended pharmacologic therapies among non-institutional- Conclusion We observed a significant gap between ized US adults with HF. adherence and control of HF risk factors and treatment Methods We examined data from US adults aged among non-institutionalized US adults. 18 years and older with a self-reported history of HF from the US National Health and Nutrition Examination Survey 1 Introduction 2007–2008 and 2009–2010. We estimated the proportions of subjects
American Journal of Cardiovascular Drugs – Springer Journals
Published: Oct 9, 2013
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.